Celularity (CELU) Q3 2024 Earnings — Beat Estimates

Screener

Reported December 6, 2024 · Before market open

Revenue$9.3MBeat by $4.0M

EPS-$0.73Beat by $0.67

Revenue estimate$5.3M

EPS estimate-$1.40

Next report

Nov 13, 2026 (in 2 months)

Versus estimates

Revenue

Q4 2025$4.1MIn line Q3 2025$5.3M Q1 2025$11.4M Q4 2024$18.1MBeat by $12.9M

Q3 2024$9.3MBeat by $4.0M

Q2 2024$12.1MBeat by $7.7M

Diluted EPS

Q4 2025-$0.95Beat by $0.55 Q3 2025-$0.88Beat by $0.62 Q1 2025-$0.84 Q4 2024-$0.59Beat by $0.91

Q3 2024-$0.73Beat by $0.67

Q2 2024-$0.30Beat by $1.10

FAQ

When did Celularity report Q3 2024 earnings?: Celularity (CELU) reported Q3 2024 earnings on December 6, 2024 before market open.
What were Celularity's Q3 2024 revenue and EPS?: Celularity reported revenue of $9.3M and eps of $-0.73 for Q3 2024.
Did Celularity beat estimates in Q3 2024?: Revenue beat the consensus estimate of $5.3M by $4.0M. EPS beat the consensus estimate of $-1.40 by $0.67.
Where can I find Celularity's Q3 2024 SEC filings?: You can read the 10-Q periodic report (0000950170-24-115082) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Celularity reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk